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OBJECTIVES: Colorectal cancer is the third leading cause of cancer death in the United States. The American
College of Gastroenterology recommends screening for first-degree relatives of patients diagnosed with
colorectal cancer before the age of 50. A colonoscopy is one of the most commonly recommended exams due to
its specificity and the possibility to resect pre-malignant lesions. Nevertheless, the rate of physician adherence to
this recommendation is unknown.
METHODS: This transversal study was performed at a major cancer center in Brazil with 62 patients, aged 18 to
50, who completed a questionnaire on information received from their physicians regarding screening their
first-degree relatives. We used the answers from patients who provided explicit consent.
RESULTS: Two hundred and three patients were eligible to participate and 93 (45.8%) agreed to complete the
questionnaire. Twenty-three questionnaires (24.73%) were returned and 39 were completed by telephone. Of
the patients who answered the questionnaire, 39 (62.9%) had received a colonoscopy recommendation for
their first-degree relatives and 23 (37.1%) were not informed of the recommendation. Among the patients who
received the recommendations, 20.51% affirmed that all relatives completed the exam and 51.28% stated that
no relatives completed the exam.
DISCUSSION: The adherence rate of our physicians to the ACG guideline recommendations was 62.9%.
Considering that our study was performed at a leading center for cancer treatment in Latin America, we had
expected better adherence. The results show that adherence to the colorectal cancer screening recommenda-
tions for high-risk patients must be improved.
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’ INTRODUCTION
Colorectal cancer is the third most common malignant
disease and the third most frequent cause of cancer-related
death in the United States (1). Despite improved results from
chemotherapy and biological agents over recent years, an
early diagnosis remains an important factor in determining a
better prognosis. The chance of developing colorectal cancer is
influenced by lifestyle, age and a familial history of colorectal
cancer (3). Familial history is the most well studied of the risk
factors. Many hereditary syndromes associated with colorectal
cancer have been described, such as adenomatous familiar
polyposis (FAP) and hereditary non-polyposis colorectal
cancer. To enhance early diagnoses, especially in patients
with a familial history of colorectal cancer, certain institutions,
such as the American College of Gastroenterology, the
American Cancer Society, the US Multi-Society Task Force
on Colorectal Cancer and the American College of Radiology
have developed guidelines for clinical practice regarding
colorectal cancer screening (8,9).
Evidence from different studies has indicated reduced
mortality in sporadic colorectal cancer cases due to screening
using different methods (11-16) and colonoscopy is one of the
most effective screening exams (8-16,17,2,7,18-33).
Despite the importance of screening programs in colorectal
cancer prevention and mortality reduction, we know little
regarding physician adherence to the guideline recommen-
dations. Based on the recognized impact of colorectal cancerDOI: 10.6061/clinics/2015(10)07
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screening, which reduces mortality, we performed this study
to evaluate physician adherence to the American College of
Gastroenterology’s recommendations on colonoscopy for
patients’ relatives at high risk of colorectal cancer.
’ METHODS
This was a transversal study that evaluated physician
adherence to screening recommendations for the first-degree
relatives of patients who were diagnosed with colorectal
cancer before the age of 50 at a major cancer center (Instituto
do Câncer do Estado de São Paulo do Hospital das Clínicas
da Faculdade de Medicina da Universidade de São Paulo,
Brazil).
The study was approved by the institutional ethics
committee.
We provided questionnaires to patients who attended this
tertiary center between July 2007 and January 2010. The
questionnaire evaluated the information that patients
received from their physicians on screening options for
their first-degree relatives. Eligible patients were contacted
by phone and invited to participate in the study. Through
this call, the patient had an opportunity to ask questions
related to the study. The patients who accepted the opportu-
nity to participate in the study received the questionnaire
by mail.
The patients were instructed to complete the questionnaire
and informed consent forms and return them to the hospital.
Incomplete questionnaires were completed by telephone.
The patients were contacted by telephone when the ques-
tionnaire were not sent back in two months.
In addition to the information provided by the ques-
tionnaire, other specific information, such as the date of
diagnosis, treatments received, cancer histological type,
tumor localization and cancer stage, were obtained from
patient records after we received patient consent.
The data obtained from the questionnaires and through
the patient records were tabulated. The results are shown
below.
Patient selection
All patients diagnosed with colorectal cancer before the
age of 50 were identified based on an administrative list.
Patients with International Classification of Diseases 18, 19
and 20 (colon, rectosigmoid junction and rectum) were used.
Patients must have fulfilled the inclusion criteria to be
eligible for the study.
Eligibility
Patients were between 18 and 50 years of age and had
been diagnosed with colorectal cancer and completed all
treatments or were in treatment with more than 12 months of
follow-up.
Patients with neuropsychiatric diseases that prevented
consent or understanding and answering the questionnaire
were excluded.
Questionnaire description
The questionnaire contained demographic data, data
regarding the patient’s disease and questions regarding the
recommendations that the patients received from their
physicians.
Additional demographic data and information regarding
the disease were collected from patient records. The obtained
information included the date of birth, gender, date of
diagnosis, treatments performed, tumor stage, tumor loca-
tion and histology.
The questionnaire evaluated whether the physicians
recommended screening with a colonoscopy or another
screening exam to the patients’ first-degree relatives.
Except for colonoscopy, we did not specify another exam
to avoid influencing patient answers.
Finally, the patients whose doctors recommended a
screening exam for their relatives were asked about the
content of this recommendation. We asked the patient the
age that their siblings should begin screening and how often
the exam should be completed.
Data analysis
The main goal of this study was evaluate physician
adherence to colonoscopy recommendations for patients
with a high risk of developing colorectal cancer.
The literature data are limited for supporting a calculation
of the sample size required for this study and we estimated
a sample size of between 80 and 100 patients.
The questionnaire that the patients answered allowed us to
generate categorical variables and provide a descriptive data
analysis, wherein variables were described as percentages.
We compared the sample obtained in this study with the
total population, which we considered all patients who met
the criteria. A simple t test was used to compare age, and two
Mann-Whitney tests were performed to compare tumor
localization and cancer stage between the two groups
’ RESULTS
We selected the first 400 patients less than 50 years of age
who were diagnosed with colorectal cancer and admitted to
the hospital between June 2007 and January 2010. Among
these patients, we selected those that fulfilled the inclusion
criteria. Patients with metastasis (tumor stage IV) were
excluded from the study because they were considered to be
in treatment and, therefore, ineligible. Among the 400
patients, 11 (2.75%) were deceased when the study began.
The records of another 27 patients (6.75%) were incomplete
without information on cancer stage and metastasis. Thus,
these patients were excluded from the study. An additional
158 patients (39.5%) presented with metastasis or were under
clinical investigation and were thus also excluded.
Thus, 204 patients (51%) were considered eligible for the
study. One of the patients was 15 years of age and was
excluded. The other 203 patients received up to four phone
calls. In these phone calls, the patients were invited to
participate in the research. Of these 203 patients, 93 (45.8%)
agreed to participate, 46 patients (22.7%) could not be
contacted and, finally, 64 patients (31.5%) refused to partici-
pate. The questionnaires and terms of informed consent were
sent to the 93 patients who agreed to participate.
Of the 93 patients who received the questionnaire, 23
returned it for an initial adherence rate of 24.73% (23/93). To
improve adherence, the researchers phoned the patients and
obtained 39 additional responses, which yielded a total of
62 patients. During the research, of the 93 patients, 6 patients
died and another two patients who were initially included
in the study were not diagnosed with colorectal cancer
and were seen at the hospital due to a familial history of
FAP. Therefore, among the 93 patients who were initially
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considered eligible to answer the questionnaire, 85 were
truly eligible.
We obtained answers from 62 of the 85 patients, which is
an adherence rate of 72.94%.
Among the patients who did not answer the questionnaire,
9 changed their telephone number and were impossible to
contact. Another 14 patients did not answer the phone calls.
The sample profile (62 patients) is shown in Table 1.
Population study and sample
Two hundred and three patients were considered eligible
to participate the study. Among these, 62 patients (30.54%)
comprised the sample. A simple test t showed that the
sample had the same median age of the total population
(43.38 and 41.91 years, respectively). These two groups were
compared using a Mann-Whitney non-parametric test for
tumor location and cancer stage, and there were no
significant differences between the groups (p=0.9671 and
p=0.7799, respectively).
Questionnaires analyses
The study evaluated physician adherence to colonoscopy
recommendations for first-degree relatives of young patients
diagnosed with colorectal cancer. Of the 62 patients in the
research, 39 (62.9%) received a colonoscopy recommendation
for their first-degree relatives. The other 23 patients (37.1%)
were not informed of the recommendation.
Among the 23 patients who had not received the
colonoscopy recommendation, 2 received a fecal occult blood
test (FOBT) recommendation. Twenty-one patients (33.88%)
did not receive a screening exam recommendation for their
first-degree relatives.
Of the 39 patients who received a colonoscopy recom-
mendation for their first-degree relatives, 26 (66.7%) received
information regarding the screening age, 9 (23%) did not
remember whether they received the information and 4
(10.3%) did not receive the information from their physicians.
One patient received incomplete information.
Information regarding the frequency of colonoscopy was
provided to 20 patients (51.28%). Fifteen patients (38.46%)
did not remember, and 4 patients (10.26%) never received the
information. The recommended screening frequency was
correct for all patients who received the recommendation.
The study also evaluated adherence of the patient and
patient’s relatives to the physician recommendations.
Among the 39 patients who received the information,
8 patients (20.51%) affirmed that all of their siblings
underwent a colonoscopy, 10 patients (25.64%) stated that
some siblings completed the colonoscopy and, finally,
20 patients (51.28%) stated that no sibling was screened.
One patient did not know if their siblings had been
examined.
The patients whose siblings did not complete the colono-
scopy were asked to provide one or more reasons that
explain why their relatives did not complete the exam.
The most common causes were fear, ignorance of the
importance of completing the exam, difficulty accessing
the exam in the public health system and disinterest of the
relatives (Table 2).
’ DISCUSSION
This transversal study evaluated 62 patients at a major
cancer center in Brazil. The sample was similar to the total
population of the study with regard to aspects such as age,
tumor site and tumor stage. The rate of patients who
received colorectal cancer screening recommendations for
their first-degree relatives based on the American College of
Gastroenterology guidelines was 62.9%. Among those
patients, 20.51% affirmed that all relatives completed the
exam and 51.28% indicated that no relative completed the
exam.
The literature on colorectal cancer screening is vast and
many studies have compared examination methods and
reported new exam techniques or discussed a local experi-
ence with screening. However, data on screening for the
general population are scarce and the authors found no data
on how often physicians recommend screening to the first-
degree relatives of patients diagnosed with colorectal cancer
before the age of 50.
The publication we considered most relevant to this
subject is a CDC report with results of a population survey
using the Behavioral Risk Factor Surveillance System
(BRFSS) (17). Through the BRFSS, a randomized population
in the US atX50 years old was evaluated for use of the FOBT
and/or sigmoidoscopy or colonoscopy. In 2006, 60.8% of
the respondents reported having completed a FOBT one
Table 1 - Sample profile.
Age Number Percentage
18-20 0 0
21-30 3 4.83
31-40 14 22.58
41-50 45 72.59
Cancer stage
I 4 6.45
IIA 15 24.2
IIB 8 12.9
IIIA 4 6.45
IIIB 14 22.58
IIIC 7 11.29
Data not available 10 16.13
Tumor location
Colon (right, left and sigmoid) 36 58.06
Rectosigmoid junction 3 4.84
Rectal 23 37.1
Table 2 - Questionnaire analysis.
Total Percentage
Did patients receive a colonoscopy recommendation for their first-degree
relatives?
Yes 39 62.9
No 23 37.1
Did patients receive a recommendation for other screening exams?
Yes 2 8.69
No 21 91.31
Did patients receive adequate information about screening age?
Yes 26 66.7
No 4 10.3
Do not remember 9 23
Adherence of patients and their relatives to the physician´s
recommendations
All relatives received a colonoscopy 8 20.51
Some relatives received a colonoscopy 10 25.64
No relative received a colonoscopy 20 51.28
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year before the survey and 55.7% reported completing
a sigmoidoscopy or colonoscopy within the ten years before
the survey. Finally, 29.5% of the respondents reported never
being tested.
The BRFSS evaluated individuals in the general popula-
tion and not necessarily those with a high risk for
developing colorectal cancer; nevertheless, 60.8% of
respondents had completed at least one type of screening
exam. Our study showed that, in a hospital that specializes
in cancer treatment, only 62.9% of patients diagnosed with
colorectal cancer received information from their doctors
recommending that their first-degree relatives complete a
screening examination. It should be noted that the relatives
of these patients were individuals with a high risk for
developing colorectal cancer. Even more worrisome is the
fact that, even when the patient received the appropriate
recommendations, more than 50% of the families comple-
tely ignored them.
Studies in which patients receive questionnaires by
mail and must return them to researchers are subject to a
natural selection bias. This study was also subjected to
an appraiser bias because many questionnaires were
completed by telephone. Other methodological limitations
of this study include a low number of patients and
relatively low rate of patient adherence to the study. We
also note that this is a single-center study conducted in a
public academic hospital and may not reflect reality at
other hospitals.
The hospital where this research took place is a leading
center in cancer treatment in Latin America and, thus, we
expected a higher adherence rate to ACG guidelines. The
results are far from our ideal and showed that colorectal
cancer screening for high-risk patients must improve. The
best way to improve the rate of screening in high-risk
patients is teaching and encouraging doctors to recom-
mend a colonoscopy. The low adherence of the patientś
relatives to the physicians’ recommendations is another
aspect that should improve. The patients and their
relatives should be educated on the importance of screen-
ing for preventing and reducing of mortality in colorectal
cancer and patient access to a colonoscopy should be
facilitated.
This transversal study, despite its methodological
limitations, takes an unprecedented approach and focuses
on a neglected subject that has great importance for in
public health: doctor use of guideline recommendations.
This study takes a different approach and evaluates the
rate of physician adherence rather than patient adherence;
it also indicates a need for constant education and
reinforcement of screening guideline recommendations
for doctors.
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